Marcin Kosmalski

Lodz, LD 92213, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Metabolic Health: The Interplay Between NAFLD, MAFLD, MASLD, and Cardiovascular Disease.

Metabolic Health: The Interplay Between NAFLD, MAFLD, MASLD, and Cardiovascular Disease.

Journal: Life (Basel, Switzerland)

Published: July 13, 2026

Peripheral Expression Profiles of Glutathione Reductase and miR-144 in Patients with Atrial Fibrillation.

Peripheral Expression Profiles of Glutathione Reductase and miR-144 in Patients with Atrial Fibrillation.

Journal: Medical sciences (Basel, Switzerland)

Published: July 07, 2026

Altered Mitochondrial Base Excision Repair and Mitochondrial DNA Instability in Peripheral Leukocytes of Patients with MASLD.

Altered Mitochondrial Base Excision Repair and Mitochondrial DNA Instability in Peripheral Leukocytes of Patients with MASLD.

Journal: Cells

Published: June 26, 2026

Clinically Inferred Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Association with Atrial Fibrillation Subtypes: A Prospective Clinical and Cardiometabolic Analysis.

Clinically Inferred Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Association with Atrial Fibrillation Subtypes: A Prospective Clinical and Cardiometabolic Analysis.

Journal: Life (Basel, Switzerland)

Published: May 28, 2026

Systemic Molecular Alterations of TP53, SIRT-1, and miR-34a Expression in Atrial Fibrillation: A Prospective Exploratory Biomarker Study.

Systemic Molecular Alterations of TP53, SIRT-1, and miR-34a Expression in Atrial Fibrillation: A Prospective Exploratory Biomarker Study.

Journal: International journal of molecular sciences

Published: April 13, 2026

Single-Nucleotide Polymorphisms in Genes Associated with Mitochondrial and DNA Damage Response Modulate the Risk of Non-Alcoholic Fatty Liver Disease in Humans.

Single-Nucleotide Polymorphisms in Genes Associated with Mitochondrial and DNA Damage Response Modulate the Risk of Non-Alcoholic Fatty Liver Disease in Humans.

Journal: International journal of molecular sciences

Published: April 10, 2026

PAPP-A Protein Diagnostic and Prognostic Significance in Acute Coronary Syndromes Without Persistent ST-T-Segment Elevation.

PAPP-A Protein Diagnostic and Prognostic Significance in Acute Coronary Syndromes Without Persistent ST-T-Segment Elevation.

Journal: Journal of clinical medicine

Published: January 01, 2026

Good Dietary Control Significantly Improves Anthropometric and Metabolic Parameters and Liver Function in Patients with Type 2 Diabetes Mellitus-A Pilot Study.

Good Dietary Control Significantly Improves Anthropometric and Metabolic Parameters and Liver Function in Patients with Type 2 Diabetes Mellitus-A Pilot Study.

Journal: Nutrients

Published: November 06, 2025

Crosstalk Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Atrial Fibrillation: Shared Mechanism, Diagnostic Integration, and Management Implications.

Crosstalk Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Atrial Fibrillation: Shared Mechanism, Diagnostic Integration, and Management Implications.

Journal: Life (Basel, Switzerland)

Published: September 28, 2025

The Impact of Comorbidities on Pulmonary Function Measured by Spirometry in Patients After Percutaneous Cryoballoon Pulmonary Vein Isolation Due to Atrial Fibrillation.

The Impact of Comorbidities on Pulmonary Function Measured by Spirometry in Patients After Percutaneous Cryoballoon Pulmonary Vein Isolation Due to Atrial Fibrillation.

Journal: Journal of clinical medicine

Published: July 01, 2025

Comparison of High-Charge Protocol vs. Dose Titration Protocol in Bilateral ECT: Evaluation of Antidepressant Effectiveness and EEG Parameters.

Comparison of High-Charge Protocol vs. Dose Titration Protocol in Bilateral ECT: Evaluation of Antidepressant Effectiveness and EEG Parameters.

Journal: Journal of clinical medicine

Published: June 22, 2025

Non-Alcoholic Fatty Liver Disease in Everyday Clinical Practice: From Diagnosis to Therapy.

Non-Alcoholic Fatty Liver Disease in Everyday Clinical Practice: From Diagnosis to Therapy.

Journal: Life (Basel, Switzerland)

Published: February 19, 2025

Showing 1-12 of 53

Last Updated: 09/26/2026